IL17A and neoplasm: After RFA, we observed enrichment of tumor growth- and immune/inflammatory response-associated GO terms and signaling pathways (such as several binding processes, positive regulation of NF-kappaB transcription factor activity, neutrophil chemotaxis, positive regulation of the inflammatory response, and the IL-17 signaling pathway) and dysregulation of protein expression, suggesting that the different statuses of DEGs and DEPs during posttranslational processes and the malignant functional transformation of DEGs were significantly associated with local tumor inflammation/immunity.